Inactive Instrument

Eagle Health Holdings Limited Stock

Equities

EHH

AU000000EHH5

Dynamic Chart
Eagle Health Holdings Limited Announces Board Changes CI
Eagle Health Holdings Limited Announces Management Changes CI
Eagle Health Holdings Limited Announces Resignation of Gang Xu as Managing Director CI
Eagle Health Holdings Limited Withdraws Final Dividend for the Year Ended December 31, 2019 CI
Eagle Health Holdings Limited Informs Delay Financial Statements for the Year Ending 31 December 2019 CI
Eagle Expands Manufacturing Facilities for Medical Masks; Secures First Purchase Order for its Disposable Medical Masks from Hainan Yiling Medical Industry Development Co., Ltd CI
Eagle Health Holdings Limited Announces Executive Changes CI
Eagle Health Holdings Limited Announces Final Dividend for the Year Ended December 31, 2019, Payable on April 30, 2020 CI
Eagle Health Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Eagle Health Holdings Limited & Amka Products Ltd Enter into Collaboration Agreement CI
Eagle & Zoono Announces Agreement for Distributing Zoono's Products in China CI
Eagle Health Holdings Limited announced that it expects to receive AUD 5 million in funding from Acuity Capital Pty. Ltd. CI
Eagle Health Awards Competitive Five-Year Contract Providing Comprehensive Occupational Medical Services to Support the National Institutes of Health CI
Eagle Health Holdings Limited announced that it has received AUD 1 million in funding CI
Eagle Health Holdings Limited announced that it expects to receive AUD 1 million in funding CI
More news
Managers TitleAgeSince
Director of Finance/CFO - 20-09-01
Chairman 60 16-12-08
Chief Tech/Sci/R&D Officer 59 -
Members of the board TitleAgeSince
Chairman 60 16-12-08
Director/Board Member 58 17-01-30
Director/Board Member - 16-12-31
More insiders
Eagle Health Holdings Limited is a vertically integrated nutritional product company. The Company is involved in the development, manufacture, marketing and distribution of health food and nutritional products. The Company's products include ejio series, amino acid series, teabag tea, protein powder, maca series, hemp series and dendrobium series. The Company distributes its products through a broad range of channels, including pharmacies, health food stores, trading companies, supermarkets and online channels, covering 23 provinces and autonomous regions throughout China. The Company involved in developing research and development (R&D) relationships with Australian universities and institutions. The Company has 18 patents in China, including 4 invention patents.
Sector
-
More about the company